PBSV has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
PBSV has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.
Pharma-Bio Serv's adjusted free cash flow per share for the three months ended in Jan. 2024 was $0.032. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $0.03 for the trailing ten years ended in Jan. 2024.
During the past 12 months, Pharma-Bio Serv's average Cyclically Adjusted FCF Growth Rate was -50.00% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was -17.00% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was -9.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.
During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Pharma-Bio Serv was -9.10% per year. The lowest was -18.90% per year. And the median was -16.35% per year.
As of today (2024-04-28), Pharma-Bio Serv's current stock price is $0.735. Pharma-Bio Serv's Cyclically Adjusted FCF per Share for the quarter that ended in Jan. 2024 was $0.03. Pharma-Bio Serv's Cyclically Adjusted Price-to-FCF of today is 24.50.
During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Pharma-Bio Serv was 32.67. The lowest was 4.71. And the median was 13.83.
The historical data trend for Pharma-Bio Serv's Cyclically Adjusted FCF per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pharma-Bio Serv Quarterly Data | ||||||||||||||||||||
Apr19 | Jul19 | Oct19 | Jan20 | Apr20 | Jul20 | Oct20 | Jan21 | Apr21 | Jul21 | Oct21 | Jan22 | Apr22 | Jul22 | Oct22 | Jan23 | Apr23 | Jul23 | Oct23 | Jan24 | |
Cyclically Adjusted FCF per Share | Get a 7-Day Free Trial | 0.06 | 0.05 | 0.05 | 0.04 | 0.03 |
For the Health Information Services subindustry, Pharma-Bio Serv's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Providers & Services industry and Healthcare sector, Pharma-Bio Serv's Cyclically Adjusted Price-to-FCF distribution charts can be found below:
* The bar in red indicates where Pharma-Bio Serv's Cyclically Adjusted Price-to-FCF falls into.
E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.
What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?
Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.
If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.
We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
For example, Pharma-Bio Serv's adjusted Free Cash Flow per Share data for the three months ended in Jan. 2024 was:
Adj_FreeCashFlowPerShare | = | Free Cash Flow per Share | / | CPI of Jan. 2024 (Change) | * | Current CPI (Jan. 2024) |
= | 0.032 | / | 129.4194 | * | 129.4194 | |
= | 0.032 |
Current CPI (Jan. 2024) = 129.4194.
Pharma-Bio Serv Quarterly Data
Free Cash Flow per Share | CPI | Adj_FreeCashFlowPerShare | |
201404 | -0.040 | 100.023 | -0.052 |
201407 | 0.042 | 100.520 | 0.054 |
201410 | 0.056 | 100.176 | 0.072 |
201501 | 0.004 | 98.604 | 0.005 |
201504 | -0.026 | 99.824 | -0.034 |
201507 | -0.016 | 100.691 | -0.021 |
201510 | 0.040 | 100.346 | 0.052 |
201601 | -0.015 | 99.957 | -0.019 |
201604 | -0.003 | 100.947 | -0.004 |
201607 | -0.018 | 101.524 | -0.023 |
201610 | -0.011 | 101.988 | -0.014 |
201701 | -0.004 | 102.456 | -0.005 |
201704 | -0.041 | 103.167 | -0.051 |
201707 | -0.022 | 103.278 | -0.028 |
201710 | 0.025 | 104.070 | 0.031 |
201801 | 0.065 | 104.578 | 0.080 |
201804 | 0.007 | 105.708 | 0.009 |
201807 | 0.073 | 106.324 | 0.089 |
201810 | 0.017 | 106.695 | 0.021 |
201901 | -0.010 | 106.200 | -0.012 |
201904 | -0.037 | 107.818 | -0.044 |
201907 | -0.028 | 108.250 | -0.033 |
201910 | -0.024 | 108.577 | -0.029 |
202001 | 0.065 | 108.841 | 0.077 |
202004 | -0.069 | 108.173 | -0.083 |
202007 | 0.053 | 109.318 | 0.063 |
202010 | 0.014 | 109.861 | 0.016 |
202101 | 0.025 | 110.364 | 0.029 |
202104 | -0.051 | 112.673 | -0.059 |
202107 | 0.019 | 115.183 | 0.021 |
202110 | 0.042 | 116.696 | 0.047 |
202201 | -0.014 | 118.619 | -0.015 |
202204 | -0.020 | 121.978 | -0.021 |
202207 | 0.048 | 125.002 | 0.050 |
202210 | 0.011 | 125.734 | 0.011 |
202301 | 0.038 | 126.223 | 0.039 |
202304 | -0.011 | 127.992 | -0.011 |
202307 | 0.042 | 128.974 | 0.042 |
202310 | 0.013 | 129.810 | 0.013 |
202401 | 0.032 | 129.419 | 0.032 |
Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.
If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.
For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.
Pharma-Bio Serv's Cyclically Adjusted Price-to-FCF of today is calculated as
Cyclically Adjusted Price-to-FCF | = | Share Price | / | Cyclically Adjusted FCF per Share |
= | 0.735 | / | 0.03 | |
= | 24.50 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Pharma-Bio Serv was 32.67. The lowest was 4.71. And the median was 13.83.
Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.
Thank you for viewing the detailed overview of Pharma-Bio Serv's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Elizabeth Plaza | 10 percent owner | 363 DORADO BEACH EAST, DORADO PR 00646 |
Altura Victor Sanchez | officer: President and CEO | C/O PHARMA-BIO SERV, INC., 6 ROAD 696, DORADO PR 00646 |
San Juan Holdings | 10 percent owner | 255 PONCE DE LEON, SUITE 305 MCS PLAZA, SAN JUAN PR 00917 |
Pedro J Lasanta | officer: Chief Financial Officer | 373 MENDEZ VIGO, STE 110, DORADO PR 00646 |
Dov Perlysky | director | 2 LAKESIDE DRIVE WEST, LAWRENCE NY 11559 |
L P Venturetek | 10 percent owner | C/O DAVID SELENGUT ELLENOFF GROSSMAN, 370 LEXINGTON AVENUE 19TH FLOOR, NEW YORK NY 10017 |
Barron Partners Lp | 10 percent owner | 730 FIFTH AVENUE, 25TH FLOOR, NEW YORK NY 10019 |
Manuel O Morera | officer: Chief Financial Officer | 373 MENDEZ VIGO, SUITE 110, DORADO PR 00646 |
Mark A Fazio | officer: Exec. Vice President and COO | P O BOX 1026 GREEN STREET, PERKASIE PA 18944 |
Kirk Wheeler Michel | director | 209 EAST TRYON STREET, HILLSBOROUGH NC 27278 |
Irving L Wiesen | director | 1273 NORTH AVENUE, APT 1E 7, NEW ROCHELLE NY 10804 |
Howard Spindel | director | 39 BROADWAY SUITE 3300, NEW YORK NY 10028 |
Nelida Plaza Rodriguez | officer: Vice President and Secretary | G11 CALLE MADRE PERLA URB, DORADO DEL MAR, DORADO PR 00646 |
Krovim Llc | director, 10 percent owner, officer: Manager | P.O. BOX 339, LAWRENCE NY 11559 |
From GuruFocus
By ACCESSWIRE AccessWire • 04-12-2019
By ACCESSWIRE ACCESSWIRE • 06-15-2021
By ACCESSWIRE ACCESSWIRE • 02-01-2021
By [email protected] [email protected] • 03-17-2020
By ACCESSWIRE ACCESSWIRE • 02-12-2022
By ACCESSWIRE • 09-15-2023
By ACCESSWIRE ACCESSWIRE • 11-15-2021
By ACCESSWIRE • 12-21-2023